SCHEMBL5164754

SCHEMBL5164754

O=[N+]([O-])c1cc2c(cc1O)OCCO2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.62
ALDH1A1 P00352 8/20 0.53
HTT P42858 1/20 0.50
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
POLB P06746 1/20 0.49
MCL1 Q07820 1/20 0.49
LMNA P02545 2/20 0.48
MAPK1 P28482 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.44
GPR35 Q9HC97 2/20 0.44
HPGD P15428 2/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 1/20 0.44
SRC P12931 1/20 0.44
PKM P14618 1/20 0.44
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RAB9A P51151 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30225775 1.00 MAPT (0.62) MAPTALDH1A1HTTMEN1KMT2A
SCHEMBL608096 0.89 MAPT (0.62) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL1625765 0.86 MAPT (0.74) MAPTALDH1A1HTTMEN1KMT2A
SCHEMBL3435482 0.82 MAPT (0.47) MAPTALDH1A1HTTMEN1KMT2A
SCHEMBL1624146 0.77 MAPT (1.00) MAPTALDH1A1HTTMEN1KMT2A
SCHEMBL5977699 0.77 MAPT (0.62) MAPTALDH1A1HTTMEN1KMT2A
SCHEMBL31000979 0.77 MAPT (1.00) MAPTALDH1A1HTTMEN1KMT2A
SCHEMBL10928322 0.77 MAPT (0.68) MAPTALDH1A1HTTMEN1KMT2A
SCHEMBL3519630 0.77 MAPT (0.62) MAPTALDH1A1HTTMEN1KMT2A
SCHEMBL19776107 0.77 MAPT (0.62) MAPTALDH1A1HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-60045586-A None JP disclosed
US-12616193-B2 5-(1H-indol-3-yl)-oxazole, -oxadiazole and -furan derivatives as enhancers of sperm motility SPERMATECH AS (NO) 2026-05-05 US disclosed
US-20230263155-A1 5-(1H-INDOL-3-YL)-OXAZOLE, -OXADIAZOLE AND -FURAN DERIVATIVES AS ENHANCERS OF SPERM MOTILITY SPERMATECH AS (NO) 2023-08-24 US disclosed
EP-1765808-A1 BISARYLUREA DERIVATIVES USEFUL FOR INHIBITING CHK1 ICOS Corporation (US) 2007-03-28 EP disclosed
WO-2006012308-A1 BISARYLUREA DERIVATIVES USEFUL FOR INHIBITING CHK1 ICOS CORPORATION (US) 2006-02-02 WO disclosed
JP-S6045586-A THIONOPHOSPHORIC ACID AMIDE DERIVATIVE, ITS PREPARATION AND PLANT BLIGHT CONTROLLING AGENT CONTAINING SAID DERIVATIVE AS ACTIVE COMPONENT SUMITOMO CHEM CO LTD 1985-03-12 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12616193-B2 5-(1H-indol-3-yl)-oxazole, -oxadiazole and -furan derivatives as enhancers of sperm motility NR5A1, CATSPER1, HCN3 MAPT 4866/4885ALDH1A1 813/4885HTT 1185/4885
US-20230263155-A1 5-(1H-INDOL-3-YL)-OXAZOLE, -OXADIAZOLE AND -FURAN DERIVATIVES AS ENHANCERS OF SPERM MOTILITY NR5A1, NR1I3, NR5A2 MAPT 4855/4885ALDH1A1 1219/4885HTT 968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.